Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Praxis Precision Medicines, Inc.PRAX · Entity 3538 | Principal Accounting Officer | May 14, 2026 | May 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Praxis Precision Medicines, Inc.
Report date May 14, 2026 · Filed May 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,572.656 |
Reported balance
After 2026-05-14 transaction · row 1
1 source rowRow 1 · 2026-05-14 · Grant · Acquired 127 · Balance 13,572.656 F1: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2026 Filed May 20, 2026 01:45 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 127 | $167.94 | $21,328.76 |
DisclosureSEC source: 0001827639-26-000007 · wk-form4_1779241539.xml · nonDerivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,572.656 F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 01:20 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 344 | $275.74 | $94,854.56 |
DisclosureSEC source: 0001827639-26-000005 · wk-form4_1768353630.xml · nonDerivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,445.656 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units. Read SEC document |
| January 10, 2026 Filed Jan 12, 2026 22:51 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 367 | $288.45 | $105,861.15 |
DisclosureSEC source: 0001689548-26-000014 · wk-form4_1768258260.xml · nonDerivative · entry 2 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,789.656 F2 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 22:51 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $294.38 | $0.00 |
DisclosureSEC source: 0001689548-26-000014 · wk-form4_1768258260.xml · derivative · entry 3 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2036-01-08 F3 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on January 8, 2027 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 22:51 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001689548-26-000014 · wk-form4_1768258260.xml · nonDerivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,156.656 F1 · kind: Ms. Mastrocola was awarded 3,750 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on the one-year anniversary of the vesting commencement date of January 8, 2026. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 21:47 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 35 | $292.63 | $10,242.05 |
DisclosureSEC source: 0001827639-26-000002 · wk-form4_1767995270.xml · nonDerivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,406.656 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:39 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,250 | $0.00 Strike: $56.94 | $0.00 |
DisclosureSEC source: 0001104659-25-115098 · tm2531977-1_4seq1.xml · derivative · entry 16 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,376 Underlying: Common Stock · 5,250 shares Expires 2034-07-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The shares underlying this stock option vested as to 7/48ths on July 29, 2024 and the remaining shares vest in substantially equal monthly installments over the following 41 months, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:39 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,351 | $0.00 Strike: $44.40 | $0.00 |
DisclosureSEC source: 0001104659-25-115098 · tm2531977-1_4seq1.xml · derivative · entry 15 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 981 Underlying: Common Stock · 2,351 shares Expires 2033-01-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The shares underlying this stock option vested as to 25% on January 12, 2024 and the remaining shares vest in substantially equal monthly installments over the following 36 months, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:39 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionStock Option (Right to Buy) · Derivative | 207 | $0.00 Strike: $44.40 | $0.00 |
DisclosureSEC source: 0001104659-25-115098 · tm2531977-1_4seq1.xml · derivative · entry 14 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 207 shares Expires 2033-01-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:39 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,680 | $0.00 Strike: $43.37 | $0.00 |
DisclosureSEC source: 0001104659-25-115098 · tm2531977-1_4seq1.xml · derivative · entry 13 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,320 Underlying: Common Stock · 2,680 shares Expires 2034-01-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The shares underlying this stock option vested as to 50% on January 12, 2024 and the remaining 50% vesting over a four-year period, with 25% of such shares vesting on January 12, 2025 and the remaining vesting in substantially equal monthly installments over the following 36 months, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:39 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,557 | $0.00 Strike: $133.65 | $0.00 |
DisclosureSEC source: 0001104659-25-115098 · tm2531977-1_4seq1.xml · derivative · entry 12 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,557 shares Expires 2030-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was fully vested as of September 8, 2024. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:39 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionStock Option (Right to Buy) · Derivative | 508 | $0.00 Strike: $83.85 | $0.00 |
DisclosureSEC source: 0001104659-25-115098 · tm2531977-1_4seq1.xml · derivative · entry 11 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 508 shares Expires 2030-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option was fully vested as of May 28, 2024. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:39 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,047 | $0.00 Strike: $49.50 | $0.00 |
DisclosureSEC source: 0001104659-25-115098 · tm2531977-1_4seq1.xml · derivative · entry 10 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,047 shares Expires 2029-09-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was fully vested as of January 1, 2023. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:39 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | SaleCommon Stock | 2,145 | $192.71 | $413,365.10 |
DisclosureSEC source: 0001104659-25-115098 · tm2531977-1_4seq1.xml · nonDerivative · entry 9 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,441.656 F2 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $192.552 to $193.109. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:39 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | SaleCommon Stock | 11,455 | $191.96 | $2,198,878.89 |
DisclosureSEC source: 0001104659-25-115098 · tm2531977-1_4seq1.xml · nonDerivative · entry 8 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,586.656 F1 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $191.500 to $192.432. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:39 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionCommon Stock | 5,250 | $56.94 | $298,935.00 |
DisclosureSEC source: 0001104659-25-115098 · tm2531977-1_4seq1.xml · nonDerivative · entry 7 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,041.656 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:39 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionCommon Stock | 2,351 | $44.40 | $104,384.40 |
DisclosureSEC source: 0001104659-25-115098 · tm2531977-1_4seq1.xml · nonDerivative · entry 6 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,791.656 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:39 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionCommon Stock | 207 | $44.40 | $9,190.80 |
DisclosureSEC source: 0001104659-25-115098 · tm2531977-1_4seq1.xml · nonDerivative · entry 5 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,440.656 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:39 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionCommon Stock | 2,680 | $43.37 | $116,231.60 |
DisclosureSEC source: 0001104659-25-115098 · tm2531977-1_4seq1.xml · nonDerivative · entry 4 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,233.656 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:39 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionCommon Stock | 1,557 | $133.65 | $208,093.05 |
DisclosureSEC source: 0001104659-25-115098 · tm2531977-1_4seq1.xml · nonDerivative · entry 3 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,553.656 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:39 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionCommon Stock | 508 | $83.85 | $42,595.80 |
DisclosureSEC source: 0001104659-25-115098 · tm2531977-1_4seq1.xml · nonDerivative · entry 2 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,996.656 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:39 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionCommon Stock | 1,047 | $49.50 | $51,826.50 |
DisclosureSEC source: 0001104659-25-115098 · tm2531977-1_4seq1.xml · nonDerivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,488.656 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:29 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 40 | $85.40 | $3,416.00 |
DisclosureSEC source: 0001689548-25-000026 · wk-form4_1739568570.xml · nonDerivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,441.656 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units. Read SEC document |
| January 12, 2025 Filed Jan 14, 2025 23:51 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 390 | $63.15 | $24,628.50 |
DisclosureSEC source: 0001689548-25-000016 · wk-form4_1736898659.xml · nonDerivative · entry 2 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,481.656 F2 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 23:51 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $63.15 | $0.00 |
DisclosureSEC source: 0001689548-25-000016 · wk-form4_1736898659.xml · derivative · entry 3 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2035-01-10 F3 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on January 10, 2026 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 23:51 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001689548-25-000016 · wk-form4_1736898659.xml · nonDerivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,871.656 F1 · shares: Ms. Mastrocola was awarded 5,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on the one-year anniversary of the vesting commencement date of January 10, 2025. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| January 07, 2025 Filed Jan 9, 2025 00:50 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 35 | $77.52 | $2,713.20 |
DisclosureSEC source: 0001689548-25-000007 · wk-form4_1736383818.xml · nonDerivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,871.656 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| November 14, 2024 Filed Nov 16, 2024 02:30 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,374 | $0.00 Strike: $56.94 | $0.00 |
DisclosureSEC source: 0001104659-24-119843 · tm2428636-1_4seq1.xml · derivative · entry 3 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,626 Underlying: Common Stock · 4,374 shares Expires 2034-07-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares underlying this stock option vested as to 7/48ths on July 29, 2024 and the remaining shares vest in substantially equal monthly installments over the following 41 months, subject to the reporting person's continued service through each vesting date. Read SEC document |
| November 14, 2024 Filed Nov 16, 2024 02:30 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | SaleCommon Stock | 5,188.344 | $81.78 | $424,318.34 |
DisclosureSEC source: 0001104659-24-119843 · tm2428636-1_4seq1.xml · nonDerivative · entry 2 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,612.656 F1 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $81.23 to $81.797. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 14, 2024 Filed Nov 16, 2024 02:30 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionCommon Stock | 4,374 | $56.94 | $249,055.56 |
DisclosureSEC source: 0001104659-24-119843 · tm2428636-1_4seq1.xml · nonDerivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,801 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2024 Filed Nov 20, 2024 02:50 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 294 | $37.40 | $10,995.60 |
DisclosureSEC source: 0001104659-24-120748 · tm2428929-2_4seq1.xml · nonDerivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,906.656 F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| July 29, 2024 Filed Aug 1, 2024 01:01 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 21,000 | $0.00 Strike: $56.94 | $0.00 |
DisclosureSEC source: 0001104659-24-084504 · tm2420554-2_4seq1.xml · derivative · entry 2 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2034-07-29 F2 · derivative.exercise_date: The shares underlying this stock option vested as to 7/48ths on July 29, 2024 and the remaining shares vest in substantially equal monthly installments over the following 41 months, subject to the reporting person's continued service through each vesting date. Read SEC document |
| July 29, 2024 Filed Aug 1, 2024 01:01 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-084504 · tm2420554-2_4seq1.xml · nonDerivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,427 F1 · shares: Ms. Mastrocola was awarded 4,500 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on January 12, 2025, subject to the reporting person's continued service through each vesting date. The restricted stock units have no expiration date. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:14 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 48 | $44.65 | $2,143.20 |
DisclosureSEC source: 0001689548-24-000027 · wk-form4_1707945236.xml · nonDerivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,927 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| January 12, 2024 Filed Jan 17, 2024 21:47 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $43.37 | $0.00 |
DisclosureSEC source: 0001689548-24-000018 · wk-form4_1705528014.xml · derivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2034-01-12 F1 · derivative.exercise_date: The shares underlying this stock option vest as follows: 50% vested in full on January 12, 2024 (the "Grant Date") and the remaining 50% vesting over a four-year period, with 25% of such shares vesting on the first anniversary of the Grant Date and the remaining shares vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| January 07, 2024 Filed Jan 10, 2024 02:08 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 35 | $25.19 | $881.65 |
DisclosureSEC source: 0001689548-24-000005 · wk-form4_1704852471.xml · nonDerivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,975 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| February 12, 2023 Filed Feb 14, 2023 01:43 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 711 | $3.94 | $2,801.34 |
DisclosureSEC source: 0001689548-23-000048 · wf-form4_167633900969675.xml · nonDerivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,160 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| January 12, 2023 Filed Jan 13, 2023 12:43 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 3,110 | $0.00 Strike: $2.96 | $0.00 |
DisclosureSEC source: 0001689548-23-000015 · wf-form4_167361377763317.xml · derivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,110 Underlying: Common Stock · 3,110 shares Expires 2033-01-12 F1 · shares: Ms. Mastrocola opted to receive this option grant in lieu of a cash bonus for the fiscal year ended December 31, 2022. Read SEC document |
| January 12, 2023 Filed Jan 18, 2023 00:30 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $2.96 | $0.00 |
DisclosureSEC source: 0001689548-23-000024 · wf-form4_167400181408222.xml · derivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2033-01-12 F1 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on January 12, 2024 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| January 07, 2023 Filed Jan 9, 2023 23:16 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 520 | $2.52 | $1,310.40 |
DisclosureSEC source: 0001689548-23-000006 · wf-form4_167330616920258.xml · nonDerivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,871 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 20:52 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $2.12 | $0.00 |
DisclosureSEC source: 0001689548-22-000094 · wf-form4_165610393075032.xml · derivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2032-06-22 F1 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on June 22, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 20:35 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | PurchaseCommon Stock | 3,000 | $1.93 | $5,775.00 |
DisclosureSEC source: 0001689548-22-000082 · wf-form4_165584373130613.xml · nonDerivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,391 Read SEC document |
| May 13, 2022 Filed May 18, 2022 21:46 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 2,557 | $8.80 | $22,496.49 |
DisclosureSEC source: 0001689548-22-000046 · wf-form4_165291013839730.xml · nonDerivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,391 F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:35 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 584 | $12.85 | $7,504.40 |
DisclosureSEC source: 0001689548-22-000005 · wf-form4_164497172165661.xml · nonDerivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,834 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:07 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 21,000 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001104659-22-003158 · tm222494-2_4seq1.xml · derivative · entry 2 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2032-01-07 F2 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on January 7, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:07 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-003158 · tm222494-2_4seq1.xml · nonDerivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,418 F1 · shares: Ms. Mastrocola was awarded 6,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on January 7, 2023, subject to the reporting person's continued service through each vesting date. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 21:56 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 48,700 | $0.00 Strike: $52.53 | $0.00 |
DisclosureSEC source: 0001689548-21-000011 · wf-form4_161359894605862.xml · derivative · entry 2 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,700 Underlying: Common Stock · 48,700 shares Expires 2031-02-12 F2 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 27,175 shares vesting on the one-year anniversary of the vesting commencement date of February 12, 2021 and the remaining 21,525 shares vesting in 36 equal monthly installments following such first anniversary, subject to the reporting person's continued service through each vesting date. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 21:56 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 8,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001689548-21-000011 · wf-form4_161359894605862.xml · nonDerivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,418 F1 · shares: Ms. Mastrocola was awarded 8,200 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on the one-year anniversary of the vesting commencement date of February 12, 2021. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 22:32 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,218 | $3.30 Strike: $3.30 | $40,319.40 |
DisclosureSEC source: 0000899243-20-030396 · doc4.xml · derivative · entry 2 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,710 Underlying: Common Stock · 12,218 shares Expires 2029-09-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of this option vested and became exercisable on January 1, 2020, with the remainder vesting in 36 equal monthly installments thereafter. This option was initially for 27,928 shares and the Reporting Person has exercised her option to purchase 12,218 shares. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 22:32 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionCommon Stock | 12,218 | $3.30 | $40,319.40 |
DisclosureSEC source: 0000899243-20-030396 · doc4.xml · nonDerivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,218 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.